Market closedNon-fractional

Sight Sciences/SGHT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Sight Sciences

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Ticker

SGHT

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Menlo Park, United States

Employees

214

Sight Sciences Metrics

BasicAdvanced
$308M
Market cap
-
P/E ratio
-$1.12
EPS
2.75
Beta
-
Dividend rate
$308M
2.75
13.007
12.223
30.856
30.856
-9.90%
-19.32%
-42.84%
3.72
2.8
2.8
-7.51
8.27%
-32.78%
39.88%
-34.74%

What the Analysts think about Sight Sciences

Analyst Ratings

Majority rating from 6 analysts.
Hold

Sight Sciences Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-84.37% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$19M
2.67%
Net income
-$16M
52.83%
Profit margin
-84.37%
48.85%

Sight Sciences Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 19.71%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.30
-$0.27
-$0.22
-$0.33
-
Expected
-$0.34
-$0.32
-$0.32
-$0.28
-$0.30
Surprise
-12.13%
-15.05%
-30.60%
19.71%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sight Sciences stock?

Sight Sciences (SGHT) has a market cap of $308M as of July 06, 2024.

What is the P/E ratio for Sight Sciences stock?

The price to earnings (P/E) ratio for Sight Sciences (SGHT) stock is 0 as of July 06, 2024.

Does Sight Sciences stock pay dividends?

No, Sight Sciences (SGHT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Sight Sciences dividend payment date?

Sight Sciences (SGHT) stock does not pay dividends to its shareholders.

What is the beta indicator for Sight Sciences?

Sight Sciences (SGHT) has a beta rating of 2.75. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Sight Sciences stock

Buy or sell Sight Sciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing